Impact of night-time symptoms in COPD: a real-world study in five European countries

David Price, Mark Small, Gary Milligan, Victoria Higgins, Esther Garcia Gil, Jordi Estruch

Research output: Contribution to journalArticle

50 Citations (Scopus)
6 Downloads (Pure)

Abstract

BACKGROUND: Sleep quality is often poor in patients with chronic obstructive pulmonary disease (COPD). A cross-sectional European survey investigated the prevalence of night-time symptoms in COPD to evaluate the level of disconnect between physician and patient perceptions of the presence of night-time symptoms, and to compare the characteristics of patients with and without night-time symptoms.

METHODS: A total of 251 primary care physicians and 251 respiratory specialists completed record forms on 2,807 patients with COPD. The forms captured information on patient demographics, lung function, COPD severity, and symptoms. Patients completed questionnaires on the time of day when their COPD symptoms bothered them, and the impact of COPD on their ability to get up in the morning and on sleep. Data were compared between groups (those with and without night-time symptoms) using t-tests or Wilcoxon signed rank tests. The kappa statistic was used to assess the level of disconnect between physician and patient perceptions of the impact of night-time symptoms.

RESULTS: Most patients (78%) reported night-time disturbance. Patients with night-time symptoms experienced more daytime breathlessness (mean modified Medical Research Council dyspnea scale score 2.4 versus 1.1) and exacerbations in the previous 12 months (mean 1.7 versus 0.4), and received more maintenance therapy (mean of 2.8 versus 2.3 products) than those without. Concordance between the frequency of physician-reported (67.9% of patients) and patient-reported (68.5% of patients) night-time symptoms was good. Physicians significantly underestimated the impact of COPD on the patient's ability to get up in the morning and on sleep (fair-moderate agreement). Physician-reported night-time symptoms were present for 41.2% of patients who could be categorized by Global initiative for chronic Obstructive Lung Disease (GOLD) group (n=937), increasing from 20.9% of those in the low-risk group to 77.4% of those in the high-riskgroup.

CONCLUSION: Patients with COPD experience night-time symptoms regardless of GOLD group, that impact on their ability to get up in the morning and on their sleep quality.

Original languageEnglish
Pages (from-to)595-603
Number of pages9
JournalInternational journal of chronic obstructive pulmonary disease
Volume8
DOIs
Publication statusPublished - 27 Nov 2013

Fingerprint

Chronic Obstructive Pulmonary Disease
Aptitude
Physicians
Sleep
Dyspnea
Primary Care Physicians
Nonparametric Statistics
Biomedical Research
Cross-Sectional Studies
Demography

Keywords

  • Activities of Daily Living
  • Aged
  • Circadian Rhythm
  • Cost of Illness
  • Europe
  • Female
  • Health Status
  • Humans
  • Lung
  • Male
  • Middle Aged
  • Pulmonary Disease, Chronic Obstructive
  • Quality of Life
  • Questionnaires
  • Retrospective Studies
  • Severity of Illness Index
  • Sleep
  • Sleep Disorders
  • Time Factors

Cite this

Impact of night-time symptoms in COPD : a real-world study in five European countries. / Price, David; Small, Mark; Milligan, Gary; Higgins, Victoria; Gil, Esther Garcia; Estruch, Jordi.

In: International journal of chronic obstructive pulmonary disease , Vol. 8, 27.11.2013, p. 595-603.

Research output: Contribution to journalArticle

Price, David ; Small, Mark ; Milligan, Gary ; Higgins, Victoria ; Gil, Esther Garcia ; Estruch, Jordi. / Impact of night-time symptoms in COPD : a real-world study in five European countries. In: International journal of chronic obstructive pulmonary disease . 2013 ; Vol. 8. pp. 595-603.
@article{0fa9b8722e1247b2b79937cf0e052afe,
title = "Impact of night-time symptoms in COPD: a real-world study in five European countries",
abstract = "BACKGROUND: Sleep quality is often poor in patients with chronic obstructive pulmonary disease (COPD). A cross-sectional European survey investigated the prevalence of night-time symptoms in COPD to evaluate the level of disconnect between physician and patient perceptions of the presence of night-time symptoms, and to compare the characteristics of patients with and without night-time symptoms.METHODS: A total of 251 primary care physicians and 251 respiratory specialists completed record forms on 2,807 patients with COPD. The forms captured information on patient demographics, lung function, COPD severity, and symptoms. Patients completed questionnaires on the time of day when their COPD symptoms bothered them, and the impact of COPD on their ability to get up in the morning and on sleep. Data were compared between groups (those with and without night-time symptoms) using t-tests or Wilcoxon signed rank tests. The kappa statistic was used to assess the level of disconnect between physician and patient perceptions of the impact of night-time symptoms.RESULTS: Most patients (78{\%}) reported night-time disturbance. Patients with night-time symptoms experienced more daytime breathlessness (mean modified Medical Research Council dyspnea scale score 2.4 versus 1.1) and exacerbations in the previous 12 months (mean 1.7 versus 0.4), and received more maintenance therapy (mean of 2.8 versus 2.3 products) than those without. Concordance between the frequency of physician-reported (67.9{\%} of patients) and patient-reported (68.5{\%} of patients) night-time symptoms was good. Physicians significantly underestimated the impact of COPD on the patient's ability to get up in the morning and on sleep (fair-moderate agreement). Physician-reported night-time symptoms were present for 41.2{\%} of patients who could be categorized by Global initiative for chronic Obstructive Lung Disease (GOLD) group (n=937), increasing from 20.9{\%} of those in the low-risk group to 77.4{\%} of those in the high-riskgroup.CONCLUSION: Patients with COPD experience night-time symptoms regardless of GOLD group, that impact on their ability to get up in the morning and on their sleep quality.",
keywords = "Activities of Daily Living, Aged, Circadian Rhythm, Cost of Illness, Europe, Female, Health Status, Humans, Lung, Male, Middle Aged, Pulmonary Disease, Chronic Obstructive, Quality of Life, Questionnaires, Retrospective Studies, Severity of Illness Index, Sleep, Sleep Disorders, Time Factors",
author = "David Price and Mark Small and Gary Milligan and Victoria Higgins and Gil, {Esther Garcia} and Jordi Estruch",
year = "2013",
month = "11",
day = "27",
doi = "10.2147/COPD.S48570",
language = "English",
volume = "8",
pages = "595--603",
journal = "International journal of chronic obstructive pulmonary disease",
issn = "1176-9106",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Impact of night-time symptoms in COPD

T2 - a real-world study in five European countries

AU - Price, David

AU - Small, Mark

AU - Milligan, Gary

AU - Higgins, Victoria

AU - Gil, Esther Garcia

AU - Estruch, Jordi

PY - 2013/11/27

Y1 - 2013/11/27

N2 - BACKGROUND: Sleep quality is often poor in patients with chronic obstructive pulmonary disease (COPD). A cross-sectional European survey investigated the prevalence of night-time symptoms in COPD to evaluate the level of disconnect between physician and patient perceptions of the presence of night-time symptoms, and to compare the characteristics of patients with and without night-time symptoms.METHODS: A total of 251 primary care physicians and 251 respiratory specialists completed record forms on 2,807 patients with COPD. The forms captured information on patient demographics, lung function, COPD severity, and symptoms. Patients completed questionnaires on the time of day when their COPD symptoms bothered them, and the impact of COPD on their ability to get up in the morning and on sleep. Data were compared between groups (those with and without night-time symptoms) using t-tests or Wilcoxon signed rank tests. The kappa statistic was used to assess the level of disconnect between physician and patient perceptions of the impact of night-time symptoms.RESULTS: Most patients (78%) reported night-time disturbance. Patients with night-time symptoms experienced more daytime breathlessness (mean modified Medical Research Council dyspnea scale score 2.4 versus 1.1) and exacerbations in the previous 12 months (mean 1.7 versus 0.4), and received more maintenance therapy (mean of 2.8 versus 2.3 products) than those without. Concordance between the frequency of physician-reported (67.9% of patients) and patient-reported (68.5% of patients) night-time symptoms was good. Physicians significantly underestimated the impact of COPD on the patient's ability to get up in the morning and on sleep (fair-moderate agreement). Physician-reported night-time symptoms were present for 41.2% of patients who could be categorized by Global initiative for chronic Obstructive Lung Disease (GOLD) group (n=937), increasing from 20.9% of those in the low-risk group to 77.4% of those in the high-riskgroup.CONCLUSION: Patients with COPD experience night-time symptoms regardless of GOLD group, that impact on their ability to get up in the morning and on their sleep quality.

AB - BACKGROUND: Sleep quality is often poor in patients with chronic obstructive pulmonary disease (COPD). A cross-sectional European survey investigated the prevalence of night-time symptoms in COPD to evaluate the level of disconnect between physician and patient perceptions of the presence of night-time symptoms, and to compare the characteristics of patients with and without night-time symptoms.METHODS: A total of 251 primary care physicians and 251 respiratory specialists completed record forms on 2,807 patients with COPD. The forms captured information on patient demographics, lung function, COPD severity, and symptoms. Patients completed questionnaires on the time of day when their COPD symptoms bothered them, and the impact of COPD on their ability to get up in the morning and on sleep. Data were compared between groups (those with and without night-time symptoms) using t-tests or Wilcoxon signed rank tests. The kappa statistic was used to assess the level of disconnect between physician and patient perceptions of the impact of night-time symptoms.RESULTS: Most patients (78%) reported night-time disturbance. Patients with night-time symptoms experienced more daytime breathlessness (mean modified Medical Research Council dyspnea scale score 2.4 versus 1.1) and exacerbations in the previous 12 months (mean 1.7 versus 0.4), and received more maintenance therapy (mean of 2.8 versus 2.3 products) than those without. Concordance between the frequency of physician-reported (67.9% of patients) and patient-reported (68.5% of patients) night-time symptoms was good. Physicians significantly underestimated the impact of COPD on the patient's ability to get up in the morning and on sleep (fair-moderate agreement). Physician-reported night-time symptoms were present for 41.2% of patients who could be categorized by Global initiative for chronic Obstructive Lung Disease (GOLD) group (n=937), increasing from 20.9% of those in the low-risk group to 77.4% of those in the high-riskgroup.CONCLUSION: Patients with COPD experience night-time symptoms regardless of GOLD group, that impact on their ability to get up in the morning and on their sleep quality.

KW - Activities of Daily Living

KW - Aged

KW - Circadian Rhythm

KW - Cost of Illness

KW - Europe

KW - Female

KW - Health Status

KW - Humans

KW - Lung

KW - Male

KW - Middle Aged

KW - Pulmonary Disease, Chronic Obstructive

KW - Quality of Life

KW - Questionnaires

KW - Retrospective Studies

KW - Severity of Illness Index

KW - Sleep

KW - Sleep Disorders

KW - Time Factors

U2 - 10.2147/COPD.S48570

DO - 10.2147/COPD.S48570

M3 - Article

VL - 8

SP - 595

EP - 603

JO - International journal of chronic obstructive pulmonary disease

JF - International journal of chronic obstructive pulmonary disease

SN - 1176-9106

ER -